PRA Health Sciences | 08-Jun-2020
| Technical / White Paper
The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...
We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...
PRA Health Sciences | 04-May-2020
| Technical / White Paper
Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...
When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...
Contract manufacturers are required to heavily invest in building new facilities. Thanks to its strategic choices of investment moves and the adoption...
Baxter BioPharma Solutions | 01-Mar-2020
| Technical / White Paper
Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....
Frontage Laboratories | 01-Dec-2019
| Technical / White Paper
Biologics are complex large molecules derived from living organisms or manufactured from cells, and they have inherent structural heterogeneity. Indeed,...
Frontage Laboratories | 01-Oct-2019
| Technical / White Paper
Over the years, the pharmaceutical industry has made steady progress in improving the safety of drugs in development. Consequently, in 2015, only 14 percent...
Frontage Laboratories | 01-Oct-2019
| Technical / White Paper
Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...
Telstar Life Science Solutions | 30-Sep-2019
| Case Study
A new vacuum induced nucleation method in the freeze-drying process, Telstar Lyonuc, reduces the duration of the primary drying cycle and ensures the homogenization...
Frontage Laboratories | 21-Aug-2019
| Technical / White Paper
Immunogenicity is the leading reason that biologics fail in clinical trials, and thus it has become imperative for drug development programs to include...
The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...
BBK Worldwide | 24-Jul-2019
| Technical / White Paper
Despite growing evidence, the myth that physicians won’t refer patients to clinical trials persists, perpetuated by the belief that they fear losing their...
I Holland Limited - Tabletting Science | 24-Jun-2019
| Case Study
Tablet sticking is one of the most common problems in tablet manufacture. Find out how I Holland used the TSAR scientific predictive model and expert tablet...
Frontage Laboratories | 19-Jun-2019
| Technical / White Paper
Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...
